KIELTYKA GLADKOWSKI KG LEGAL IS A PROUD CONTRIBUTOR TO CHAMBERS AND PARTNERS GLOBAL PRACTICE GUIDE LIFE SCIENCES 2025
Publication date: April 07, 2025
KIELTYKA GLADKOWSKI has made a contribution to new edition of Chambers and Partners Global Practice Guide Life Sciences 2025, where our lawyers provided insights into:
- Polish Healthcare Cybersecurity
- Use of Artificial Intelligence in the Life Sciences Sector, including the use of AI in clinical trials and pharmacovigilance
- Good Automated Manufacturing Practice (GAMP) 5 guidelines
- New EU and Polish provisions on Medical Device Conformity Assessment
- Problems Encountered by Foreign Drug Manufacturers Conducting Clinical Trials in Poland, including problems with compassionate use and extended access procedures
- Access to Medicinal Products for Patients, including greater information requirements, e-prescriptions
- New regulations on Medical Cannabis (pharmaceutical raw material, online platforms, online consultations)
- Regulations on the sale of over-the-counter (OTC) drugs, in pharmacies and multi-sector stores
- New Regulations for Health Apps (Digital Therapeutics) and possibilities to obtain Ministry of Health Certified Apps
- Food and nutrition safety regulations, the supervision of the Chief Sanitary Inspectorate and the RASFF database.
- Investments in the Life Sciences Sector in Poland and Financing Models
- Technology Transfers in the Life Sciences Sector
We kindly invite you to read the content here: https://practiceguides.chambers.com/practice-guides/life-sciences-2025/poland/trends-and-developments
